title: A Wnt inhibitor with a twist.
abstract: Although the clinical safety of compounds targeting the core components of the Wnt signaling pathway remains to be determined, a simple in vivo chemical screen identifies small molecules that inhibit Wnt signaling in a cell type-specific manner (Ni et al., this issue of Chemistry & Biology).
authors.affiliation: Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA. jyeh1@partners.org
authors.forename: Jing-Ruey J
authors.initials: JR
authors.lastname: Yeh